# Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

> **NCT00570622** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 20 (actual)

## Conditions studied

- Cirrhosis
- Ascites
- Portal Hypertension

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00570622
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2008-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00570622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00570622, "Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00570622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*